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ABSTRACT
Purpose: The purpose of the present study was to validate an experimental model for assessing 
tissue integration of titanium and zirconia implants with and without buccal dehiscence defects.
Methods: In 3 dogs, 5 implants were randomly placed on both sides of the mandibles: 1) 
Z1: a zirconia implant (modified surface) within the bony housing, 2) Z2: a zirconia implant 
(standard surface) within the bony housing, 3) T: a titanium implant within the bony housing, 
4) Z1_D: a Z1 implant placed with a buccal bone dehiscence defect (3 mm), and 5) T_D: a 
titanium implant placed with a buccal bone dehiscence defect (3 mm). The healing times 
were 2 weeks (one side of the mandible) and 6 weeks (the opposite side).
Results: The dimensions of the peri-implant soft tissue varied depending on the implant and 
the healing time. The level of the mucosal margin was located more apically at 6 weeks than 
at 2 weeks in all groups, except group T. The presence of a buccal dehiscence defect did not 
result in a decrease in the overall soft tissue dimensions between 2 and 6 weeks (4.80±1.31 
and 4.3 mm in group Z1_D, and 4.47±1.06 and 4.5±1.37 mm in group T_D, respectively). 
The bone-to-implant contact (BIC) values were highest in group Z1 at both time points 
(34.15%±21.23% at 2 weeks, 84.08%±1.33% at 6 weeks). The buccal dehiscence defects in 
groups Z1_D and T_D showed no further bone loss at 6 weeks compared to 2 weeks.
Conclusions: The modified surface of Z1 demonstrated higher BIC values than the surface 
of Z2. There were minimal differences in the mucosal margin between 2 and 6 weeks in the 
presence of a dehiscence defect. The present model can serve as a useful tool for studying 
peri-implant dehiscence defects at the hard and soft tissue levels.
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INTRODUCTION
Titanium implants are commonly used to rehabilitate function following tooth loss [1]. A 
variety of preclinical and clinical studies have demonstrated that titanium dental implants 
exhibit excellent biocompatibility [2] and yield high survival and success rates [3].
Even though clinically successful, potential disadvantages of titanium implants include 
hypersensitivity to titanium, corrosion of the material, and esthetic problems, predominantly 
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in thin gingival tissues [4-6]. In order to overcome these limitations and to meet patients' 
demands for metal-free dental implants and reconstructions, dental implants made of 
zirconia were introduced [7]. The hard and soft tissue integration of zirconia implants has 
been thoroughly investigated in preclinical studies [8-10], but only limited scientific evidence 
is available comparing titanium and zirconia implants in the same experimental model.
Successful tissue integration of dental implants relies on osseointegration (at the hard tissue 
level) and the formation of a peri-implant mucosal seal (at the soft tissue level). The key 
parameters for assessing osseointegration are measurements of bone-to-implant contact 
(BIC) and removal torque values [7]. The majority of studies demonstrated no significant 
differences for those parameters between titanium and zirconia implants [11,12]. Moreover, 
at the soft tissue level, from a quantitative and qualitative point of view, the dimensions of 
the peri-implant mucosa around zirconia implants are similar to those around titanium 
implants [13,14].
The transition from bone-driven to a prosthetically-driven implant placement often results 
in buccal bone dehiscence defects [15]. Traditionally, exposed implant threads were treated 
using guided bone regenerative procedures. While this increases the treatment time and cost, 
observational studies demonstrated that not all dental implants were completely surrounded 
by bone in the longer term [16,17]. Still, the majority of these implants were considered to 
be clinically successful, as judged by a stable mucosal margin (MM). More recent clinical 
data also suggested that small buccal dehiscence defects might not require guided bone 
regeneration, at least in the short term [15]. These observations are thought to be due to 
a tight mucosal seal at the soft tissue level. Zirconia dental implants associated with high 
biocompatibility and reduced plaque accumulation are speculated to be even more tissue-
friendly [7]. Comparative evidence of titanium and zirconia dental implants with untreated 
buccal dehiscence defects is therefore needed. Currently, no preclinical experimental model 
has been used to study such defects, as it requires a chronic hard tissue defect (similar to a 
clinical situation).
The aim of the present study was to validate an experimental model for assessing tissue 
integration of titanium and zirconia implants with and without buccal dehiscence defects.
MATERIALS AND METHODS
The present study was designed as a pilot experimental study. A total of 3 mongrel dogs 
(2 years old) weighing a maximum of 30 kg were used. The dogs were housed individually 
under standard laboratory conditions. Access to water ad libitum and a soft diet were provided 
throughout the entire study period. The protocol was approved by the Institutional Animal 
Care and Use Committee, Yonsei Medical Center, Seoul, Korea (approval No. 2016-0278).
Surgical procedures
All surgical procedures were performed under general anesthesia. General anesthesia was 
induced by an intravenous injection of atropine (0.04 mg/kg, Kwangmyung Pharmaceutical, 
Seoul, Korea) and an intramuscular injection of a combination of xylazine (Rompun, 
Bayer Korea, Seoul, Korea) and ketamine (Ketara, Yuhan Corporation, Seoul, Korea). 
Inhalation anesthesia (Gerolan, Choongwae Pharmaceutical, Seoul, Korea) was maintained 
throughout surgery.
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Tooth extraction and creation of chronic defects
All mandibular premolars (P1, P2, P3, and P4) and the first molar (M1) were bilaterally extracted 
8 weeks prior to implant placement. A crevicular incision from P1 to M1 was made, as well as 
2 vertical incisions at the mesial side of P1 and the distal side of M1. The mucoperiosteal flap 
was reflected and the teeth were carefully extracted. Then, a one-wall defect was prepared 
by removing the buccal bone plate in the surgical sites randomized for undergoing implant 
placement with dehiscence defects. In all other sites, the extraction sockets were left intact. 
Primary wound closure was then obtained. Sutures were removed 7 days later.
Implant placement
Implant placement was performed in a staged manner on the left and right sides of the 
mandible to allow 2 healing time-points (6 weeks and 2 weeks, respectively). A mid-
crestal incision was made from the canine to the second molar, and mucoperiosteal flaps 
were reflected. Five osteotomies for implant placement were performed according to the 
manufacturer's recommendation, allocating 5 experimental groups bilaterally in each dog 
(n=3 for each healing time-point) based on a computer-generated randomization list:
1)  Z1: zirconia implant (AXIS HEXALOBE™ with a modified surface, Ø4.0×8 mm, AXIS 
biodental, Les Bois, Switzerland) placed within the bony housing,
2)  Z2: zirconia implant (AXIS HEXALOBE™, Ø4.0×8 mm, AXIS biodental) placed within 
the bony housing,
3)  T: titanium implant (CAMLOG® SCREW-LINE Promote® plus, Ø3.8×9 mm, Camlog 
Biotechnologies, Basel, Switzerland) placed within the bony housing,
4)  Z1_D: Z1 implant placed with a 3-mm buccal bone dehiscence defect,
5)  T_D: titanium implant placed with a 3-mm a buccal bone dehiscence defect.
Three (Z1, Z2, and T) of the 5 osteotomies were within the bony housing, with 2 mm of buccal 
bone present after implant placement. For the other 2 sites (Z1_D and T_D), the preparation 
of the osteotomies resulted in a buccal dehiscence defect of 3 mm. No further buccal bone 
was removed in order to maintain a chronic ridge defect (Figure 1A).
All zirconia implants were placed with the implant shoulder (IS) located 0.7 mm above the 
bone crest (BC). All titanium implants were placed with the transition between the rough 
and smooth surface at the level of the alveolar crest (the location of the IS was 0.4 mm above 
the BC). Healing abutments were connected to the implants and the flaps were sutured to 
allow for transmucosal healing. The sutures were removed 7 days later. The postsurgical 
management included daily irrigation with 0.2% chlorhexidine solution (Hexamedin, Bukwang 
Pharmaceutical, Seoul, Korea) and an intramuscular injection of antibiotics (20 mg/kg, 
cefazolin sodium, Yuhan Corporation). The dogs were sacrificed 6 weeks after the first implant 
procedure (one side of the mandible) and 2 weeks after the second implant procedure (opposite 
side of the mandible) (Figure 2). The implants and surrounding tissues were macroscopically 
inspected. Digital X-rays were taken using a standardized parallel technique (Figure 1B and C).
Histologic preparation
The harvested mandibles were fixed in 10% neutral-buffered formalin for 10 days. The 
specimens were trimmed and dehydrated in ethanol, and then embedded in methyl 
methacrylate. From each specimen, a central bucco-oral section through the implant site at 
40–50 µm thickness was prepared using the microcutting and grinding technique adapted by 
Donath and Breuner [18]. Thereafter, the sections were visualized using van Gieson staining.
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Analyses
Histometric analysis
The images from the histological slides were observed and captured using a light microscope 
(Leica DM6000 B, Leica Mikrosysteme, Wetzlar, Germany) equipped with a digital camera 
(Leica DFC 450, Leica Mikrosysteme). Subsequently, the acquired digital images were 
processed and analyzed using a software program (Photoshop CS6, Adobe, San Jose, CA, 
USA) and an automated image analysis system (Leica Application Suite Ver. 4.3, Leica 
Mikrosysteme).
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Figure 2. Detailed schedule of surgical procedures and sacrifices.
A
B C
Figure 1. Representative clinical and radiographic views. (A) Clinical photograph after implant placement. (B) 
Standardized X-rays obtained at 6 weeks (left: group Z1, right: group Z2). (C) Standardized X-rays obtained at 6 
weeks (left: group Z1_D, middle: group T_D, right: group T).
Peri-implant soft tissue dimensions and BIC
The following landmarks were located [9]: 1) the MM, 2) the IS, 3) the apical extension of 
the junctional epithelium (aJE), 4) the first bone-to-implant contact (fBIC), and 5) the BC. 
Subsequently, linear measurements were performed as follows: 1) the level of the mucosal 
margin relative to the implant shoulder (MM-IS), 2) the length of the junctional epithelium 
(MM-aJE), 3) the length of peri-implant mucosa (MM-fBIC), 4) the distance between IS and 
fBIC, with the subtraction of 0.7 mm (zirconia implant) or 0.4 mm (titanium implant) to 
account for the 2 different insertion protocols and height of the implant collars (IS-fBIC_c), 
and 5) the distance between the BC and the fBIC (BC-fBIC) (Figure 3A). Moreover, the mean 
of the buccal and lingual BIC (%) was calculated (Figure 3B).
Statistical analysis
Statistical analyses were performed descriptively to compare the intergroup differences at 2 
and 6 weeks, and the intragroup differences over time. Mean values±standard deviation for 
each parameter are presented to describe the data. Due to the small sample size, no further 
statistical tests were performed.
RESULTS
Clinical observations
All dogs remained healthy during the entire study period. Three implant fractures were 
observed: 2 in group Z1_D (one in the 2-week healing group and the other in the 6-week 
healing group) and one in group Z2. No implant lost osseointegration.
Histomorphometric analyses
The data of the linear measurements are presented in Table 1 (for the buccal side) and Table 2 
(for the lingual side). The fractured implants were only included for the measurements of BIC 
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Figure 3. Histomorphometric assessments. (A) Linear measurement. (B) BIC. 
BIC: bone-to-implant contact, MM: mucosal margin, IS: implant shoulder, aJE: apical extension of the junctional 
epithelium, BC: bone crest, fBIC: the first bone-to-implant contact.
(Table 3). Figures 3 and 4 are representative histologic views of all groups at both 2 and 6 weeks 
(Figures 4 and 5).
Peri-implant soft tissue dimensions
The mean level of the MM was located coronally relative to the IS in all groups. The mean 
MM-IS distance was highest in group T_D (2.53±1.91 mm) at 2 weeks, followed by groups 
Z2, Z1, Z1_D, and T (2.31±0.32 mm, 2.09±0.87 mm, 1.78±1.48 mm, and 1.68±0.46 mm, 
respectively). At 6 weeks, the mean MM-IS distance was consistent in the zirconia implant 
groups (Z1: 0.84±0.28 mm, Z2: 1.18±0.28 mm, Z1_D: 1.09 mm) and the titanium implant 
groups (T: 2.19±1.46 mm, T_D: 1.97±1.45 mm) (Table 1).
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Table 1. Linear measurements at the buccal area (in mm)
Parameters Z1 Z2 T Z1_D T_D
2 wk
MM-IS 2.09±0.87 (n=3) 2.31±0.32 (n=2) 1.68±0.46 (n=3) 1.78±1.48 (n=3) 2.53±1.91 (n=3)
MM-aJE 3.03±0.4 (n=3) 3.31±0.4 (n=2) 2.12±0.61 (n=3) 3.27±2.25 (n=3) 3.27±1.24 (n=3)
MM-fBIC 4.21±1.17 (n=3) 5.44±1.71 (n=2) 3.18±0.95 (n=3) 4.8±1.31 (n=3) 4.47±1.06 (n=3)
IS-fBIC_c 1.43±1.91 (n=3) 2.44±2.03 (n=2) 1.0±0.78 (n=3) 2.48±0.75 (n=2) 2.57±0.12 (n=2)
BC-fBIC 0.82±1.14 (n=3) 1.23±1.74 (n=2) 0.66±0.64 (n=3) 0.31±0.07 (n=2) 0.62±0.36 (n=2)
6 wk
MM-IS 0.84±0.28 (n=3) 1.18±0.2 (n=2) 2.19±1.46 (n=3) 1.09 (n=1) 1.97±1.45 (n=3)
MM-aJE 2.48±0.34 (n=3) 2.47±0.46 (n=2) 2.9±2.12 (n=3) 2.52 (n=1) 2.25±1.56 (n=3)
MM-fBIC 2.87±0.41 (n=3) 3.21±0.53 (n=2) 4.13±0.62 (n=3) 4.3 (n=1) 4.5±1.37 (n=3)
IS-fBIC_c 1.33±0.18 (n=3) 1.33±0.33 (n=2) 1.44±0.68 (n=3) 2.51 (n=1) 2.13±0.23 (n=3)
BC-fBIC 0.13±0.22 (n=3) 0.03±0.04 (n=2) 0.28±0.28 (n=3) 0 (n=1) 0.04±0.07 (n=3)
Values are presented as mean±standard deviation. No analyses were performed for implants that fractured.
Z1: zirconia implant with a modified surface, placed within the bony housing, Z2: zirconia implant without a modified surface, placed within the bony housing, 
T: titanium implant placed within the bony housing, Z1_D: Z1 implant placed with 3 mm of buccal bone dehiscence, T_D: titanium implant placed with 3 mm of 
buccal bone dehiscence, MM: mucosal margin, IS: implant shoulder, aJE: apical extension of the junctional epithelium, fBIC: first bone-to-implant contact, BC: 
bone crest, IS-fBIC_c: the distance between IS and fBIC, with the subtraction of 0.7 mm (zirconia implant) or 0.4 mm (titanium implant).
Table 2. Linear measurements at the lingual area (in mm)
Parameters Z1 Z2 T Z1_D T_D
2 wk
MM-IS 1.61±0.39 (n=3) 2.2±0.31 (n=2) 2.24±0.23 (n=3) 2.03±0.72 (n=3) 2.51±0.21 (n=3)
MM-aJE 2.36±0.1 (n=3) 2.64±0.25 (n=2) 3.02±0.54 (n=3) 3.33±1.22 (n=3) 3.01±0.25 (n=3)
MM-fBIC 3.38±0.56 (n=3) 3.64±0.87 (n=2) 3.69±0.42 (n=3) 4.79±1.91 (n=3) 4.33±0.73 (n=3)
IS-fBIC_c 1.07±0.2 (n=3) 0.74±0.56 (n=2) 0.96±0.42 (n=3) 2.06±2.11 (n=3) 1.33±0.55 (n=3)
BC-fBIC 0.55±0.48 (n=3) 0.58±0.21 (n=2) 1.03±0.51 (n=3) 1.83±1.82 (n=3) 1.47±0.33 (n=3)
6 wk
MM-IS 1.14±1.45 (n=3) 0.57±0.42 (n=2) 1.44±1.17 (n=3) 0.1 (n=1) 1.09±1.35 (n=3)
MM-aJE 2.23±2.01 (n=3) 1.98±0.56 (n=2) 1.47±1.21 (n=3) 0.55 (n=1) 1.18±1.25 (n=3)
MM-fBIC 3.23±1.93 (n=3) 2.61±0.59 (n=2) 2.77±0.89 (n=3) 2.31 (n=1) 2.94±0.89 (n=3)
IS-fBIC_c 1.39±0.5 (n=3) 1.34±0.17 (n=2) 0.83±0.44 (n=3) 1.51 (n=1) 1.45±0.52 (n=3)
BC-fBIC 0.16±0.17 (n=3) 0.49±0.53 (n=2) 0.38±0.32 (n=3) 0.12 (n=1) 0.74±0.24 (n=3)
Values are presented as mean±standard deviation. No analyses were performed for implants that fractured.
Z1: zirconia implant with a modified surface, placed within the bony housing, Z2: zirconia implant without a modified surface, placed within the bony housing, 
T: titanium implant placed within the bony housing, Z1_D: Z1 implant placed with 3 mm of buccal bone dehiscence, T_D: titanium implant placed with 3 mm of 
buccal bone dehiscence, MM: mucosal margin, IS: implant shoulder, aJE: apical extension of the junctional epithelium, fBIC: first bone-to-implant contact, BC: 
bone crest, IS-fBIC_c: the distance between IS and fBIC, with the subtraction of 0.7 mm (zirconia implant) or 0.4 mm (titanium implant).
Table 3. Bone-to-implant contact ratio (%)
Parameters Z1 Z2 T Z1_D T_D
2 wk 34.15±21.23 (n=3) 19.81±2.03 (n=2) 31.77±11.73 (n=3) 29.02±25.32 (n=3) 9.32±3.42 (n=3)
6 wk 84.08±1.33 (n=3) 67.26±5.11 (n=2) 77.22±4.48 (n=3) 73.59±4.57 (n=3) 65.0±14.61 (n=3)
Values are presented as mean±standard deviation.
Z1: zirconia implant with a modified surface, placed within the bony housing, Z2: zirconia implant without a modified surface, placed within the bony housing, 
T: titanium implant placed within the bony housing, Z1_D: Z1 implant placed with 3 mm of buccal bone dehiscence, T_D: titanium implant placed with 3 mm of 
buccal bone dehiscence.
The mean length of the junctional epithelium (MM-aJE) for zirconia implants without defects 
at 2 weeks was 3.03±0.4 mm (Z1) and 3.31±0.4 mm (Z2), which was larger than in group T 
(2.12±0.61 mm). The MM-aJE values in groups Z1_D (3.27±2.25 mm) and T_D (3.27±1.24 mm) 
were highly scattered compared to the defect-free groups (Z1, Z2, and T). At 6 weeks, the MM-
aJE values in groups Z1 (2.48±0.34 mm) and Z2 (2.47±0.46 mm) were less scattered than in 
the other groups and smaller than at 2 weeks. The MM-aJE in groups Z1_D, T, and T_D ranged 
from 2.25±1.56 mm (group T_D) to 2.90±2.12 mm (group T) (Table 1).
The mean length of the peri-implant mucosa (MM-fBIC) at 2 weeks was highest in group Z2 
(5.44±1.71 mm). The corresponding dimensions were 4.21±1.17 mm and 4.80±1.31 mm in 
groups Z1 and Z1_D, and 3.18±0.95 and 4.47±1.06 mm in groups T and T_D, respectively. At 
6 weeks, the MM-fBIC in groups Z1 (2.87±0.41 mm) and Z2 (3.21±0.53 mm) was smaller than 
at the 2-week time point, whereas in group T, the dimension at 6 weeks (4.13±0.62 mm) was 
larger than at 2 weeks. The MM-fBIC in groups Z1_D (4.3 mm) and T_D (4.5±1.37 mm) was 
similar at 2 and 6 weeks (Table 1).
The corrected distance between IS and fBIC (IS-fBIC_c) demonstrated minimal differences 
between 2 and 6 weeks in groups Z1, Z2, Z1_D, and T. However, in group T, the dimension of 
IS-fBIC_c was smaller at 6 weeks (2.13±0.23 mm) than at 2 weeks (2.57±0.12 mm) (Table 1).
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Figure 4. Representative histologic views at 2 weeks (van Gieson staining). (A) Group Z1. (B) Group Z2. (C) Group T. (D) Group Z1_D. (E) Group T_D. 
Z1: zirconia implant with a modified surface, placed within the bony housing, Z2: zirconia implant without a modified surface, placed within the bony housing, 
T: titanium implant placed within the bony housing, Z1_D: Z1 implant placed with 3 mm of buccal bone dehiscence, T_D: titanium implant placed with 3 mm of 
buccal bone dehiscence, B: buccal, L: lingual.
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Figure 5. Representative histologic views at 2 weeks (van Gieson staining). (A) Group Z1. (B) Group Z2. (C) Group T. (D) Group Z1_D. (E) Group T_D. 
Z1: zirconia implant with a modified surface, placed within the bony housing, Z2: zirconia implant without a modified surface, placed within the bony housing, 
T: titanium implant placed within the bony housing, Z1_D: Z1 implant placed with 3 mm of buccal bone dehiscence, T_D: titanium implant placed with 3 mm of 
buccal bone dehiscence, B: buccal, L: lingual.
BIC
The mean percentage of BIC at 2 weeks was comparable between groups Z1 (34.15%±21.23%) and 
Z1_D (29.02%±25.32%), but not between groups T (31.77%±11.73%) and T_D (9.32%±3.42%). 
The BIC in group Z2 (19.81%±2.03%) was lower than in groups Z1 and Z1_D (Table 3).
At 6 weeks, group Z1 demonstrated the highest BIC values (84.08%±1.33%) among all 
groups, followed by groups T (77.22%±4.48%), Z1_D (73.59%±4.57%), Z2 (67.26%±5.11%) 
and T_D (65.0%±14.61%).
DISCUSSION
The present pilot preclinical study investigated the validity of an experimental model for 
assessing soft and hard tissue integration following the placement of implants with and 
without chronic buccal dehiscence defects. The study demonstrated that: 1) the dimensions 
of the peri-implant soft tissue varied depending on the implant and the healing time, 2) the 
level of the MM was located more apically at 6 weeks than at 2 weeks in all groups (except 
group T), 3) the presence of a buccal dehiscence defect did not result in a decrease in the 
overall soft tissue dimension between 2 and 6 weeks (groups T_D and Z1_D), 4) BIC values 
were highest in group Z1 at both time points, and 5) buccal dehiscence defects did not 
increase up to 6 weeks (i.e., there was no further bone loss), thereby supporting the use of 
this experimental model as a tool to study tissue integration of implants with and without 
buccal dehiscence defects.
Whereas the periodontium is developed during tooth eruption, the peri-implant mucosa is 
established during the healing period after implant placement and abutment connection. 
Extensive research, predominantly on titanium implants, has demonstrated that the 
dimensions of the peri-implant mucosa are consistent, irrespective of the type of healing 
(submerged/transmucosal) and the implant system [19-21]. Based on an experimental model 
comparing titanium and zirconia dental implants over a longer healing period (range, 6–12 
months), the dimension of the peri-implant tissues did not show any significant differences 
across implant systems and materials [9,14]. In the present study, different peri-implant 
dimensions were measured at 2 weeks depending on the implant material (titanium vs. 
zirconia) and the surface (Z1 vs. Z2) (Z1: 4.21±1.17 mm, Z2: 5.44±1.71 mm, T: 3.18±0.95 mm). 
These variations might be attributed to the early healing phase and the initial soft tissue 
response [22]. At 6 weeks, the peri-implant dimensions appeared to have matured more, as 
represented by smaller within-group standard deviations. In sites without dehiscence defects, 
a larger dimension was found for titanium implants (similar to previous studies [23,24]) than 
for zirconia implants (similar to a previous study [9]).
The dimensions of the peri-implant mucosa in groups with dehiscence defects (Z1_D 
and T_D) were larger than in the corresponding defect-free groups (Z1 and T) at 2 weeks, 
indicating that the dehiscence defects were covered with soft tissue. Interestingly, these 
dimensions were maintained around both implant materials up to 6 weeks. Moreover, the 
level of the MM and the length of the junctional epithelium in groups Z1_D and T_D were not 
substantially different compared to the defect-free groups (Z1, Z2, and T). Clinically, small 
dehiscence defects are frequently encountered after implant placement due to remodeling 
processes following tooth extraction. Such deficiencies are traditionally treated by applying 
bone regenerative procedures, thereby contributing to increased patient morbidity, higher 
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cost, and an increased treatment time. In a clinical setting, a previous study compared 
titanium implants with guided bone regeneration to those that underwent spontaneous 
healing for ≤5 mm dehiscence defects, and demonstrated no statistically significant 
difference in the mucosal level between the 2 groups [15]. No such data exist for zirconia 
implants. The similar dimensions of peri-implant mucosa in the present preclinical study 
at both 2 and 6 weeks may indicate that a small dehiscence defect can be left without bone 
augmentation. However, considering the increase of bone loss observed in a clinical trial 
when small dehiscence defects were left untreated around the titanium implants [15], 
further investigations into mucosal stability at dehiscence defects are required with a larger 
number of samples. Moreover, the effects of crown insertion and occlusal loading should be 
investigated.
The percentage of BIC is often used to assess osseointegration. A systematic review based 
on preclinical studies demonstrated that most of the included studies showed no statistically 
significant difference in terms of BIC values between zirconia and titanium implants [25]. 
This is in line with the present study, in which differences were predominantly observed 
between groups Z1 and T (34.15%±21.23% vs. 31.77%±11.73% at 2 weeks, 84.08%±1.33% 
vs. 77.22%±4.48% at 6 weeks). The difference in BIC values between group Z1 and Z2 
was also notable. It appeared that group Z1 achieved a faster and higher osseointegration 
level compared to group Z2. This difference might be attributed to the differing surface 
characteristics of the 2 zirconia implants.
Implant fractures were found in 2 implants in group Z1_D and in one implant in group 
Z2, but not in any of the titanium implants. Fractures of zirconia implants were previously 
observed in preclinical studies using canine mandibles [9,10]. Both studies reported 7 
zirconia implant fractures, and the most fractures were observed for one-piece implants. 
Interestingly, the fracture was related to a specific animal in both studies. Likewise, 2 implant 
fractures (2 out of 3) in the present study were found in a single dog, suggesting that the 
specific host can be a confounding factor.
The present study employed a chronic peri-implant dehiscence model, which is more similar 
to clinical circumstances than an acute model. The establishment of a bony dehiscence 
defect in conjunction with implant placement (acute model) might render bone healing 
unpredictable, thereby reducing the standardization of outcome measures. The choice of a 
chronic defect model is even more important if the early healing phase is considered and the 
peri-implant tissues are predominantly assessed at the soft tissue level. At the time of implant 
placement in the present study, healed ridges were present. Sequential drilling and adjusting 
drill angulation made it more feasible to standardize implant placement in a predictable 
manner with or without dehiscence defects. At 6 weeks, the values of IS-fBIC_c (the distance 
between the implant shoulder and the first bone-to-implant contact) were larger in the 
groups with defects than in the defect-free groups, thereby supporting the use of the present 
experimental model.
In conclusion, variations in the peri-implant mucosal dimensions were found depending on 
the implant material, the healing time, and the presence or absence of a dehiscence defect. 
Up to 6 weeks, there were minimal differences in the marginal mucosa in the presence of 
a dehiscence defect. A zirconia implant with a modified surface (Z1) resulted in higher BIC 
values than Z2. The present chronic peri-implant dehiscence model can serve as a useful 
experimental model to study peri-implant dehiscence defects at the hard and soft tissue levels.
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